Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Clinical and Experimental Medicine|November 17, 2025
CD2AP is a disulfidptosis modulator and prognostic biomarker in hepatocellular carcinomaYingzheng Tan, Lei Yang, Qingbin Wang, et al.Frontiers in Oncology|June 1, 2022
Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular CarcinomaHongkai Zhuang, Bo Chen, Chenwei Tang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2025
Sitravatinib targets TYRO3 to augment the anti-tumor immune response of PD-1 blockade in hepatocellular carcinomaHongkai Zhuang, Chenwei Tang, Wentao Wang, et al.Cancer Letters|January 18, 2025
circCCNY enhances lenvatinib sensitivity and suppresses immune evasion in hepatocellular carcinoma by serving as a scaffold for SMURF1 mediated HSP60 degradationLei Yang, Wenliang Tan, Min Wang, et al.Angewandte Chemie (International Ed. in English)|September 21, 2021
Revealing the Side-Chain-Dependent Ordering Transition of Highly Crystalline Double-Cable Conjugated PolymersGuitao Feng, Wenliang Tan, Safakath Karuthedath, et al.Cellular Oncology (Dordrecht, Netherlands)|February 5, 2024
A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinomaHongkai Zhuang, Chenwei Tang, Han Lin, et al.Journal for Immunotherapy of Cancer|July 19, 2024
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapyYonglin Hua, Zhixian Sun, Yuxin Xiao, et al.NPJ Digital Medicine|January 16, 2026
Integrating multi-omics and machine learning systematically deciphers cellular heterogeneity and fibrotic regulatory networks in the progression from MASLD to MASHWeiheng Wen, Zenghui Liu, Wenliang Tan, et al.Apoptosis : an International Journal on Programmed Cell Death|June 2, 2024
FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinomaQingbin Wang, Wenliang Tan, Ziyu Zhang, et al.Cell Death & Disease|March 5, 2024
CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNAChenwei Tang, Hongkai Zhuang, Wentao Wang, et al.Pageof 5